特定蛋白質市場:開發平台報告(開發階段，市場區隔，地區·國家，法規途徑，主要企業等)，2022年最新版

Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

出版日期: 2022年10月27日 | 出版商:

GlobalData | 英文 82 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

本報告提供特定蛋白質市場相關調查，產品概要與正在開發的開發中產品趨勢，參與企業的最近趨勢等資訊。

Alfa Wassermann Diagnostic Technologies, LLC
Amerimmune LLC
Beckman Coulter Inc
China Medical Technologies Inc
Colorado State University
Fujirebio Diagnostics Inc
Genesis Detection Systems, Inc.
Guanine Inc
Hologic Inc
Isoformix Inc
Numares AG
Ortho Clinical Diagnostics Holdings Plc
Ottawa Hospital Research Institute
Roche Diagnostics International Ltd
Sebia SA
Siemens Healthcare Diagnostics Inc
SomaLogic Inc
Umea University
University of California

第6章特定蛋白質- 最近的開發

第7章附錄

調查手法
關於GlobalData
詢問
免責聲明

簡介目錄圖表

Product Code: GDME1464EPD

GlobalData's Medical Devices sector report, "Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Specific Proteins pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Specific Proteins are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Specific Proteins under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Specific Proteins under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date